MIRANDA RUITER: Open Payments
NPI 1770329286 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $277 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Organon LLC | 1 | $52 |
| Baxter Healthcare | 1 | $49 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Optinose US, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: DUPIXENT, PERCLOT, NUCALA, TAVNEOS, XOLAIR, NEFFY, Xhance, INSPIRE.
Industry payments across UT — which companies pay providers there.
